These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31581133)
1. KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma. Li WC; Xiong ZY; Huang PZ; Liao YJ; Li QX; Yao ZC; Liao YD; Xu SL; Zhou H; Wang QL; Huang H; Zhang P; Lin JZ; Liu B; Ren J; Hu KP Aging (Albany NY); 2019 Oct; 11(19):8169-8182. PubMed ID: 31581133 [TBL] [Abstract][Full Text] [Related]
2. The correlation and role analysis of KCNK2/4/5/15 in Human Papillary Thyroid Carcinoma microenvironment. Lin X; Wu JF; Wang DM; Zhang J; Zhang WJ; Xue G J Cancer; 2020; 11(17):5162-5176. PubMed ID: 32742463 [No Abstract] [Full Text] [Related]
3. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma. Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma. Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263 [TBL] [Abstract][Full Text] [Related]
6. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis reveals CYP2C9 as a potential prognostic marker for HCC and liver cancer cell lines suitable for its mechanism study. Shuaichen L; Guangyi W Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):70-74. PubMed ID: 29974848 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma. Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967 [TBL] [Abstract][Full Text] [Related]
10. Expression Pattern and Clinical Significance of Gab2 Protein in Hepatocellular Carcinoma. Hu X; He B; Zhou L; Xie H; Zheng S Clin Lab; 2016; 62(6):1087-92. PubMed ID: 27544933 [TBL] [Abstract][Full Text] [Related]
11. Identification of Gem as a new candidate prognostic marker in hepatocellular carcinoma. Huang X; Cong X; Yang D; Ji L; Liu Y; Cui X; Cai J; He S; Zhu C; Ni R; Zhang Y Pathol Res Pract; 2014 Nov; 210(11):719-25. PubMed ID: 25155751 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma. Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310 [TBL] [Abstract][Full Text] [Related]
13. Gelsolin-like Actin-capping Protein (CapG) Overexpression in the Cytoplasm of Human Hepatocellular Carcinoma, Associated with Cellular Invasion, Migration and Tumor Prognosis. Tsai TJ; Chao WY; Chen CC; Chen YJ; Lin CY; Lee YR Anticancer Res; 2018 Jul; 38(7):3943-3950. PubMed ID: 29970516 [TBL] [Abstract][Full Text] [Related]
14. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. Ma W; Hong Z; Liu H; Chen X; Ding L; Liu Z; Zhou F; Yuan Y Biomed Res Int; 2016; 2016():8201642. PubMed ID: 28070518 [No Abstract] [Full Text] [Related]
15. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401 [TBL] [Abstract][Full Text] [Related]
16. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma. Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
18. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
19. Clinical Significance of TRMT6 in Hepatocellular Carcinoma: A Bioinformatics-Based Study. Wang Y; Huang Q; Deng T; Li BH; Ren XQ Med Sci Monit; 2019 May; 25():3894-3901. PubMed ID: 31128068 [TBL] [Abstract][Full Text] [Related]
20. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]